Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

ational purposes only and

is not prepared in accordance with generally accepted accounting

principles. Adjusted EBITDA is defined as earnings before taxes,

depreciation, and amortization of intangible assets and non-cash

marketing expense, adjusted to exclude the impact of stock-based

compensation expense.

SUPPLEMENTAL INFORMATION: Reconciliation of Forecasted Q1 2008

and FY 2008 Net Income (Loss) Range to Forecasted

Q1 2008 and FY 2008 Adjusted EBITDA Range

Range Calculated As: Three Months Ended Twelve Months Ended

March 30, 2008 December 28, 2008

(In thousands, unless

otherwise indicated) Range High Range Low Range High Range Low

Net income (loss) $(2,350) $(2,850) $3,000 $(1,000)

Amortization of

intangible assets 250 250 900 900

Amortization of

non-cash marketing 575 575 2,300 2,300

Stock-based compensation 2,100 2,100 7,300 7,300

Depreciation 2,225 2,225 10,500 10,500

Interest income, net (400) (400) (2,000) (2,000)

Adjusted EBITDA $2,400 $1,900 $22,000 $18,000

drugstore.com, inc.

Consolidated Balance Sheets

(in thousands, except share data)

December 30, December 31,

2007 2006

(unaudited) (audited)

ASSETS

Current assets:

Cash and cash equivalents $18,572 $13,393

Marketable securities 17,677
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...k of Peers, Parents and Professionals Shares Exper...n, Employment, Recreation, More , , WASHING...a leading international disability association wor... people with significant disabilities announces th...eer resource directory accessible to people with d...
(Date:12/2/2008)...melteon show it could aid shift workers, people af...ealthDay News) -- The experimental drug tasimelteo... or night shifts, according to the results of two ...ded 39 people randomly assigned to receive either ...on, or a placebo. They were monitored for seven ni...
(Date:12/2/2008)... Dec. 2 MEDai, Inc., headquartered...rovider, has added a new module,to its existing s...and-alone,module monitors a population,s complian...ts stakeholders when there has been a deviation fr... Guidelines(TM) provides,real-time decision suppo...
(Date:12/2/2008)...s Nearly Half Have Skipped Medical Care Due to Cos...swire-USNewswire/ -- A new survey released today b...RC) highlights another troubling aspect of the cur...eek health care for themselves or their families t...men say their health has gotten worse over the pas...
Breaking Medicine News(10 mins):Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4
...sia is catching up fast with the West. Yes, but no...tunately in cancer incidence too. Smoking, drink...ous cancers will combine with larger populations ...ous diseases to drive Asian cancer rates up 60 per...
...wo Philippines examiners were charged with corrupt...mination, officials said, in a scandal that cast ...are the first two people to be charged in connecti... commission issuing a temporary ban on the 17,000 ...
...owerful Shiite politician Abdel Aziz al-Hakim retu...receiving treatment for cancer in Tehran. Hakim, ...e parliament, spent nearly two weeks abroad in a t...cal tests in the United States and treatment in Ir...
...mputees can now breathe a sigh of relief for resea...y (MIT) in Boston have developed two robotic devic...ural, energy-efficient gaits. Dr. Hugh Herr, Assi...Biomechatronics Group at the institute, has been q...
Other Medicine News:Health News:Surge in Cancer Incidence in Asia Feared 2Health News:Surge in Cancer Incidence in Asia Feared 3Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2
(Date:12/2/2008)...re-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ),...prietary antibodies for the treatment of cancer, i...ed that it has entered into an agreement expanding...th Kingsbridge Capital Limited, a private investme...bridge has committed to provide up to $75 million ...
(Date:12/1/2008)...-- TargeGen has announced that an oral,presentati...-based clinical,trial of TG101348 in myeloprolife... 2008 American Society of Hematology (ASH) Meeting...llows:, Title: A Phase I Study ... JAK2-Selective Inhibitor, in Patients w...
(Date:12/1/2008)...gene is a two-way switch that, if turned off, caus...so that they lose their identity and become more l...nn., Dec. 1 Scientists...covered that a certain differentiated cell type is...the constant expression of a gene called Prox1 t...
(Date:12/1/2008)...r Tuesday, December 9 at 11:00 am ET to Discuss Ph...N FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCal...S ), a biopharmaceutical company focused on the de...erapeutics, today announced new data from its stud...ill be presented during the 50th American Society ...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 1NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 2Easy Ethnic Election 28475 1Easy Ethnic Election 28475 2FDA Faulted for Stance on Chemical in Plastics 28471 1FDA Faulted for Stance on Chemical in Plastics 28471 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 13SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 33SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 43SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 53SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 6
...is, often conducted in a physicians office practic...array of ailments; UTIs, diabetes, several cancers...iseases. The estimated global market for urinalys...r and is growing strongly. For such a fundamental,...rocedure, the manufacturers of urinalysis analyzer...
...cois Rossi Medical Hematology and Oncology CHU Lap...RP) is an acute-phase protein that has long been r...P measurement can complement a range of diagnostic.... However, as economic rationalization becomes a ... apparent that such areas of frequent laboratory t...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4
...sively for the airlines industry:, ,AirSeps A...ured for the airlines to assist their supplemental...everal overseas airlines. With the US governments ...on specific Boeing commercial aircraft, AirSep set...
...p's LifeStyle Portable Oxygen Concentrator is the ...nywhere. At less than 10 lbs (4.5 kg), this unit w... and highly active oxygen patient., ,Operatin...logies of both an oxygen concentrator and an oxyge...
...ers up to 10 LPM of oxygen reducing the delivery c...ts. The M10 is engineered to reduce the cost of pr...parts than any other concentrator on the market. F...p you to reduce expenditure on accessories and unn...
The Hudson RCI oxygen conserving cannula incorporates a patented "split prong" nose design and two oxygen supply tubes with standard connectors. This design provides the utmost control and comfort in
Medicine Products: